pre-update Archives | Page 16 of 150 | サターラ

eBook

PBPK Applications (MIFD) Using the Simcyp™ Simulator

Explores strategies, regulatory validation, and solutions in small-molecule human Physiologically Based Pharmacokinetic modeling (PBPK).

Simona Colucci2024年8月28日

Guide

臨床試験から承認申請までサターラの統合された法令準拠の臨床データソリューション

下記のいずれかのステップをクリックして詳細を表示してください。

Danielle Pillsbury2024年8月28日

Conference

DMDG in vivo ADME one-day meeting 2024

Danielle Pillsbury2024年8月27日

ブログ

How has the Inflation Reduction Act Impacted the Biosimilars Market?

The Inflation Reduction Act (IRA), one of the key legislative achievements the Biden-Harris administration, aims…

Certara2024年8月27日

Fact Sheet

Phoenix™ NLME

Danielle Pillsbury2024年8月26日

Fact Sheet

Phoenix™ PK/PD Platform Overview

Danielle Pillsbury2024年8月26日

Article

FDA’s Lykos Rejection Delays—But Doesn’t Stop—Psychedelic Therapies

Certara's Dr. Fran Brown, Senior Vice President of Drug Development Science, is quoted in this…

Certara2024年8月26日

Publication

Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator

The article "Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system…

Danielle Pillsbury2024年8月26日

Publication

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

The article “Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL)…

Danielle Pillsbury2024年8月26日

Article

The Uncertain Path Forward for Psychedelic Medicine

Certara's Dr. Fran Brown, Senior Vice President of Drug Development Science, is quoted in this…

Certara2024年8月26日

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software